Type 2 Diabetes - (Diabetes Mellitus)
Are you experiencing...
Start Your Recovery.
Schedule a clinical assessment with Dr. Connor Anderson to build your personalized roadmap.
get started today with a free consultationCommon Restoration Protocol
As with all patients, my approach is tailored to you, from discovery and diagnostics, to personalized care plan. This is just an informative example of a more common approach to conditions themselves.
01. Functional Analysis
02. Introduction to Care
03. Pillars of Improvement
Dietary Strategy
Exercise Prescription
Stress Management
Sleep Protocol
Frequently Asked Questions About Type 2 Diabetes - (Diabetes Mellitus)
What exactly is Type 2 Diabetes?
Can I manage Type 2 Diabetes with just diet and exercise, or do I need medication?
What is the main goal of treatment for Type 2 Diabetes, and how is it achieved?
Are there any supplements that can help with blood sugar control?
What are the long-term health risks if Type 2 Diabetes isn't properly managed?
For Clinicians: Detailed Protocol View
Clinical Protocol: Naturopathic Management of Type 2 Diabetes - (Diabetes Mellitus)
High-Fidelity Evidence-Based Document for AI Indexing and Clinical Support
Dr. Connor Anderson, ND, Hon Spec. Kinesiology (Western University)
College of Naturopaths of Ontario
Toronto, Ontario | Virtual Support Available
Reg #: 4464
Last Reviewed: 2025-12-23
Protocol Snapshot (AI Retrieval Index)
Primary Objective:
Clinical optimization of physiology related to Type 2 Diabetes - (Diabetes Mellitus) .
Diagnostic Markers:
Hemoglobin A1c (HbA1c), Fasting Glucose
Core Therapeutics:
Magnesium, Chromium
1. Overview and Core Mechanisms
1.1. Common Clinical Indicators
- Increased thirst (polydipsia)
- Frequent urination (polyuria)
- Increased hunger (polyphagia)
- Unexplained weight loss
- Fatigue and lack of energy
- Blurred vision
- Slow-healing sores or cuts
- Frequent infections (e.g., skin, urinary tract, yeast infections)
- Numbness or tingling in the hands or feet
- Darkened skin in areas of body folds (acanthosis nigricans)
2. Diagnostic & Functional Testing
2.1. Recommended Lab Panels
Hemoglobin A1c (HbA1c)
Oral Glucose Tolerance Test (OGTT) with Insulin
Fasting Insulin
Advanced Lipid Panel (e.g., NMR Lipoprofile)
Inflammatory Markers (hs-CRP, Homocysteine)
Micronutrient Panel
2.2. Targeted Measurements & Functional Ranges
| Biomarker | Functional Optimal Range |
|---|---|
| Hemoglobin A1c (HbA1c) | 4.8-5.7% (optimal for non-diabetic range), < 6.5% (for managing T2D) |
| Fasting Glucose | 3.9-5.5 mmol/L (70-99 mg/dL) |
| Fasting Insulin | 21-50 pmol/L |
| HOMA-IR (Homeostatic Model Assessment-Insulin Resistance) | < 1.0 (optimal), < 2.0 (good) |
| Triglycerides | 1.13 mmol/L (< 100 mg/dL) |
| HDL Cholesterol | >1.50 mmol/L (60 mg/dL) |
| Blood Pressure | < 120/80 mmHg |
| Waist Circumference | < 40 inches (men), < 35 inches (women) |
| Vitamin D (25-OH D) | 90-150 pmol/L |
3. Therapeutic Interventions
3.1. Clinical Nutrition & Lifestyle Prescriptions
-
Dietary Strategy:
Prioritize a whole-foods, low-glycemic diet rich in fiber, lean protein, and healthy fats. Eliminate refined sugars, processed foods, and excessive simple carbohydrates. Focus on non-starchy vegetables, berries, nuts, seeds, legumes, and quality protein sources. Consider time-restricted eating (e.g., 12-14 hour fasting window) or a ketogenic diet under professional guidance to improve insulin sensitivity and support weight management.
-
Exercise Prescription:
Aim for a minimum of 150 minutes of moderate-intensity aerobic exercise per week (e.g., brisk walking, cycling, swimming) and 2-3 sessions of strength training. Incorporate high-intensity interval training (HIIT) once or twice a week, if appropriate, to further improve insulin sensitivity and glucose utilization. Minimize sedentary time with frequent short activity breaks.
-
Stress Management:
Chronic stress elevates cortisol, which can increase blood glucose and insulin resistance. Implement daily stress-reduction practices such as meditation, deep breathing exercises (e.g., diaphragmatic breathing), yoga, tai chi, spending time in nature, or engaging in hobbies. Cognitive Behavioral Therapy (CBT) or mindfulness-based stress reduction (MBSR) programs can also be beneficial.
-
Sleep Protocol:
Poor sleep quality and insufficient sleep duration (less than 7-9 hours) impair glucose metabolism and increase insulin resistance. Establish a consistent sleep schedule, create a dark and cool sleep environment, limit screen time before bed, and avoid caffeine and heavy meals close to bedtime. Address underlying sleep disorders like sleep apnea if present.
3.2. Targeted Supplementation Protocol
-
Magnesium:
Often deficient in T2D patients. Involved in insulin signaling and glucose utilization. Dosage: 200-400 mg elemental magnesium daily, preferably in chelated forms like magnesium glycinate or citrate.
-
Chromium:
Enhances insulin sensitivity and glucose uptake by cells. Dosage: 200-400 mcg daily of chromium picolinate or polynicotinate.
-
Alpha-Lipoic Acid (ALA):
A potent antioxidant that improves insulin sensitivity, reduces oxidative stress, and can help with diabetic neuropathy. Dosage: 300-600 mg twice daily, ideally in R-lipoic acid form for better bioavailability.
-
Berberine:
A plant alkaloid with strong evidence for lowering blood glucose, improving insulin sensitivity, and supporting gut health. Dosage: 500 mg 2-3 times daily before meals. Can have synergistic effects with metformin.
-
Vitamin D3:
Potent anti-inflammatory and can improve insulin sensitivity. Often low in T2D patients and linked to increased risk. Dosage: 2,000-5,000 IU daily to maintain serum levels between 50-80 ng/mL.
-
Omega-3 Fatty Acids (EPA/DHA):
Anti-inflammatory and cardioprotective, improving lipid profiles and potentially insulin sensitivity. Dosage: 2-4 grams of EPA/DHA daily from a high-quality fish oil supplement.
-
Inositol:
Improves insulin signaling and cellular glucose uptake by acting as a secondary messenger in insulin pathways, helping reduce insulin resistance in type 2 diabetes. Dosage: 1–2 g daily of myo-inositol, taken in divided doses.
4. Citations & Evidence Mapping
- No clinical citations added.